Wang, Feng
Zhou, Xiaofang
Chen, Ruiquan
Kang, Jie
Yang, Xinyi
Lin, Jinzhu
Liu, Fang
Cao, Dairong
Xing, Zhen http://orcid.org/0000-0002-2104-4681
Funding for this research was provided by:
The National Natural Science Foundation of China (82071869)
The Leading Project of the Department of Science and Technology of Fujian Province (2020Y0025)
The Natural Science Foundation of Fujian Province (2021J01706)
The Joint Funds for the Innovation of Science and Technology, Fujian Province (2020Y9102)
Article History
Received: 5 August 2022
Revised: 26 March 2023
Accepted: 8 May 2023
First Online: 13 July 2023
Declarations
:
: The scientific guarantor of this publication is Prof. Dairong Cao, The First Affiliated Hospital of Fujian Medical University.
: The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
: No complex statistical methods were necessary for this paper.
: Written informed consent was waived by the Institutional Review Board.
: Institutional Review Board approval was obtained.
: Some patients in the present study cohort overlapped with one of our studies, in which we evaluated diffusion and perfusion MRI in primary CNS lymphomas of different locations (Xing Z, Kang N, Lin Y, Zhou X, Xiao Z, Cao D (2020) BMC Med Imaging. ExternalRef removed). As for the PCNSL part, 32 cases (32%) overlapped in these two studies. In that study, the research purpose and research method were far different from our present study.
: • retrospective• diagnostic or prognostic study• performed at one institution